HUGE – fsd pharma inc. - class b subordinate voting shares (US:NASDAQ)
Stock Stats
News
FSD Pharma Inc. (NASDAQ: HUGE) had its "buy-venture" rating re-affirmed by analysts at Singular Research.
FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia
FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd(TM) in an Induced State of Alcohol Intoxication
FSD Pharma Provides Update from Celly Nu’s Partnership with Six+One for unbuzzd(TM)
FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM) [Yahoo! Finance]
Form 6-K FSD Pharma Inc. For: May 06
Form 6-K FSD Pharma Inc. For: Apr 30
Form 6-K FSD Pharma Inc. For: Apr 22
Form 6-K FSD Pharma Inc. For: Apr 22
Form 6-K FSD Pharma Inc. For: Apr 16
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.